Dysregulation of microRNAs (miRNAs) has been linked to virulence factors of Helicobacter pylori. The role of H. pylori in esophageal disease has not been clearly defined. We previously reported that H. pylori esophageal colonization promotes the incidence of Barrett's esophagus and esophageal adenocarcinoma in vivo. Here, we studied the direct effects of H. pylori on the transformation of esophageal epithelial cells, with particular focus on whether H. --
| INTRODUCTION
Chronic inflammation can promote the initiation and progression of many cancers, 1 as exemplified by the gastroesophageal reflux disease (GERD) to Barrett's esophagus to esophageal adenocarcinoma sequence. Chronic gastroesophageal reflux plays a crucial role in the development of Barrett's esophagus, a condition of columnar (intestinal) metaplasia of the esophageal squamous epithelium. 2 It has been widely accepted that this esophageal metaplasia is a precursor of esophageal adenocarcinoma. 3 The risk of developing esophageal adenocarcinoma in patients with Barrett's esophagus is 30-125 times higher than in the normal population. 4 Helicobacter pylori is a risk factor for the development of gastritis, peptic ulcer disease, and gastric cancer. 5 The association between H. pylori infection and Barrett's esophagus or esophageal adenocarcinoma is controversial. A number of studies have concluded that H. pylori infection tends to protect against Barrett's esophagus or esophageal adenocarcinoma. [6] [7] [8] In contrast, a meta-analysis showed no convincing association between H. pylori eradication and the development of GERD, 9 and eradication of H. pylori might halt the progress to esophageal adenocarcinoma in patients with GERD and Barrett's esophagus. 10 However, these studies did not evaluate the impact of H. pylori colonization sites on the development of esophageal disease. Our previous studies have indicated that, in a rat model of chronic gastroesophageal reflux, H. pylori colonization in the esophagus increased the severity of esophageal inflammation and the incidence of Barrett's esophagus and esophageal adenocarcinoma, whereas H. pylori colonization in the stomach had no influence on the esophageal mucosa. 11, 12 Thus, the effect of H. pylori on the esophagus varies with the colonization site. Both chronic gastroesophageal reflux and esophageal H. pylori infection could play important roles in the development of inflammation and Barrett's esophagus-associated carcinogenesis. Reflux of gastric contents, including acid and bile, induces metaplasia of esophageal mucosa and facilitates colonization of H. pylori in the distal esophagus, and therefore aggravates esophageal injury. Clinical data have shown the high prevalence of H. pylori in the esophagus, and its presence is correlated with signs of inflammation. 13 In Barrett's esophagus patients, the presence of metaplasia within the esophagus is a prerequisite for H. pylori colonization, and H. pylori may exacerbate inflammation in Barrett's epithelium. 14 However, the molecular mechanisms involved in the effects of H. pylori in the GERD-Barrett's esophagus-esophageal adenocarcinoma sequence remain largely unknown. We have found that H. pylori colonization was associated with overexpression of cyclooxygenase 2 (COX2) in esophageal mucosa. Celecoxib, a selective COX2 inhibitor, significantly inhibited Barrett's esophagus-associated carcinogenesis. 11 The mechanisms for the regulation of H. pylori on COX2 expression in esophageal mucosa may still need to be further investigated.
MicroRNAs (miRNAs) regulate various cellular functions, including proliferation, differentiation, and apoptosis. 15 Aberrant miRNA expression has been associated with human diseases such as inflammation and cancer. 16 Several miRNAs have been identified as being involved in the development and progression of Barrett's esophagus and esophageal adenocarcinoma. 17 Helicobacter pylori infection can modify the expression of more than 50 miRNAs in the gastric mucosa, and these miRNA levels can be restored to normal after H. pylori eradication. 18 Recent studies also show that the association of miRNA with esophageal adenocarcinoma prognosis may be influenced by H. pylori infection status, suggesting that miRNA-H. pylori interactions play an important role in the prognosis of esophageal adenocarcinoma. 19 However, none of the earlier studies examined the expression signature and the role of miRNA in H. pylori-infected esophageal epithelial cells.
In this study, we determined the long-term and direct effects of H. pylori on the phenotype of esophageal epithelia cells by using a well-established in vitro model. 20 We particularly focused on whether H. pylori exerts its effects through modulating miRNAs and their downstream target genes.
| MATERIALS AND METHODS

| Clinical samples
A total of 16 Barrett's esophagus patients with (n = 10) or without (n = 6) esophageal H. pylori colonization were enrolled in this study. 
| MicroRNA and transfection
The oligonucleotide of miRNA-212-3p mimic (5 0 -UAACAGUCUCCA
inhibitor ( 
| Western blot analysis and real-time quantitative PCR (RT-qPCR) assays
Cells were lysed with RIPA buffer. Equal amounts of protein were resolved by 10% SDS-PAGE and transferred onto PVDF membranes.
After blocking, membranes were probed with appropriate primary antibodies at 4°C overnight. Membranes were reacted with speciesspecific secondary antibodies conjugated with HRP for 1 hour at room temperature, followed by detection with enhanced chemiluminescence. All primary and secondary antibodies used for Western blot analyses were from Santa Cruz Biotechnology (Santa Cruz, CA, USA). The expression of COX2 and caudal-type homeobox protein 2 (CDX2) was quantified by densitometry analysis using ImageJ software (NIH, Bethesda, MD, USA) and normalized against b-actin.
Reverse transcription of mRNAs to cDNAs was carried out using 
| Statistical analysis
Data are expressed as mean AE SD. Differences were analyzed by Student's t-test or the non-parametric Wilcoxon and Mann-Whitney U-tests. A P-value of <.05 was considered significant. As an intestine-specific transcription factor, caudal-type homeobox protein 2 (CDX2) regulates goblet-specific MUC2 gene expression, resulting in the differentiation of intestinal epithelium.
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Normal esophageal keratinocytes do not express CDX2, which has been reported to be a highly sensitive and specific marker of intestinal metaplasia and adenocarcinoma. 22, 23 In agreement with the effect on cell morphology, treatment of HET-1A cells with H. pylori extract or acidified DCA significantly increased the mRNA expression of CDX2 and mucin 2 (MUC2), and these effects were evident at 8-12 weeks and maintained for up to 36 weeks (Figure 1Da,b) . Moreover, CDX2 and MUC2 protein expression was upregulated in cells treated with these compounds at 36 weeks (Figure 1Da,b) . Cytokeratin 5 (CK5) is expressed by normal esophageal keratinocytes but not by intestinal epithelium with metaplasia. 24 Coincidentally, with upregulated CDX2 and MUC2, the expression of CK5 also decreased in HET-1A cells treated with H. pylori extract or acidified DCA (Figure 1Dc) . Importantly, the alteration of CDX2, MUC2, and CK5 was enhanced when HET-1A cells were exposed to both two compounds. As shown in Figure 1D , after 36 weeks, the expression of Esophageal H. pylori colonization is thought to initiate esophageal carcinogenesis through the COX2 pathway. 11 As shown in Figure 1E , at the initial stage of exposure (before 12 weeks), H. pylori alone resulted in minor changes of COX2 expression, but it distinctly augmented the acidified DCA-induced COX2 in HET-1A cells. Helicobacter pylori extract plus acidified DCA led to a 9.5-fold increase of COX2 mRNA at 12 weeks, and it was maintained at high levels up to 36 weeks. Similarly, COX2 protein expression significantly increased in cells treated with the two compounds at 36 weeks ( Figure 1F ).
Thus, prolonged exposure of HET-1A cells to H. pylori seems to aggravate the tumorigenic phenotype conferred by acidified DCA.
| MicroRNA expression profiles associated with
Helicobacter pylori infection
To determine the miRNA profiles of esophageal epithelial cells associated with H. pylori infection, we carried out a microarray analysis.
Comparison Furthermore, we measured miRNA expression levels in biopsies obtained from Barrett's esophagus patients with or without H. pylori esophageal colonization. As shown in Figure 3D ,E, esophageal H. pylori colonization led to a pronounced decrease of miR-212-3p and miR-361-3p expression compared with uninfected controls. Moreover, COX2 expression was significantly increased in patients with H. pylori esophageal colonization ( Figure 3F ). Although these patients showed a trend of increased CDX2 expression, it was not statistically significant ( Figure 3G ). In Barrett's esophagus, intestinal metaplasia of esophageal epithelium facilitates colonization of H. pylori in the distal esophagus, and therefore exacerbates inflammation. Our data suggested that aberrant silencing of miR-212-3p and miR-361-3p may be involved in H. pylori-induced esophageal injury. 
| DISCUSSION
The role of H. pylori in esophageal disease has not been clearly defined. Here, we showed that exposure to H. pylori promoted acidified DCA-induced transformation of esophageal epithelial cells. In recent years, concerns have arisen that H. pylori is not "protective" against GERD, Barrett's esophagus, or esophageal adenocarcinoma. 25, 26 Both gastroesophageal reflux and H. pylori are major etiologic factors in the development of inflammation and intestinal metaplasia of the gastroesophageal junction. 27 Long-standing reflux of gastric contents is thought to induce Barrett's esophagus, and
Barrett's esophagus is associated with the increased colonization of H. pylori in the distal esophagus. 14, 28 The expected incidence of esophageal adenocarcinoma with persistent H. pylori infection is higher than that of esophageal adenocarcinoma after eradication of infection. 29 Thus, H. pylori might be involved in the GERD-Barrett's esophagus-esophageal adenocarcinoma sequence. In the present study, we analyzed the direct effects of H. pylori on the transformation of esophageal epithelial cells. Following repeated exposure to H. pylori extract or acidified DCA, HET-1A cells showed progressive morphological changes. These changes were coupled with suppressed expression of keratinocyte markers and enhanced expression of intestinal metaplasia markers. It was noteworthy that H. pylori F I G U R E 3 Helicobacter pylori decreased microRNA (miR)-212-3p and miR-361-3p expression. ET-1A and OE33 cells were cocultured with H. pylori (100 MOI) for 12 h, relative expression levels of miR-212-3p (A) and miR-361-3p (B) were analyzed by real-time quantitative PCR. C, HET-1A cells were exposed to H. pylori extract (HPE) for 36 wk and relative expression levels of miR-212-3p and miR-361-3p were determined. In Barrett's esophagus patients with or without H. pylori esophageal colonization, the expression of miR-212-3p (D), miR-361-3p (E), COX2 (F), and caudal-type homeobox protein 2 (CDX2) (G) were detected. All miRNA expression was normalized to U6 small nuclear RNA. COX2 and CDX2 mRNA expression was normalized to GAPDH. Data are expressed as mean AE SD. *P < .05. NS, not significant. All results shown are representative of three independent experiments TENG ET AL. showing that H. pylori colonization can aggravate esophageal injury and promote the incidence of Barrett's esophagus and esophageal adenocarcinoma in a model of chronic gastroesophageal reflux. 11, 12 Caudal-type homeobox protein 2 is a key factor for intestinal development. Ectopic expression of CDX2 occurs during the development and maintenance of Barrett's esophagus. 30 Bile acids can directly induce CDX2 expression and activation in Barrett's esophagus. 31 Our previous studies showed that H. pylori infection induced CDX2 expression in esophageal epithelium, playing an important role in the inflammation associated with Barrett's esophagus and tumorigenesis. 11, 12 In this in vitro model, we found CDX2
was increased in esophageal epithelial cells in response to H. pylori or acidified DCA treatment, implying that the cells underwent transformation. Chronic expression of COX2 plays a crucial role in H. pylori-associated gastric carcinogenesis. 32 Moreover, the expression of COX2 is gradually increased during the neoplastic progression of the esophageal mucosa from Barrett's esophagus to adenocarcinoma. 33 In the present study, COX2 expression in esophageal epithelial cells Helicobacter pylori infection could alter the expression and function of miRNAs through epigenetic regulations such as DNA methylation and histone modification. 34 The role of miRNA in the progression from normal esophageal mucosa to Barrett's esophagus and finally to esophageal adenocarcinoma has been established. ing translation or degradation. 35 In this study, miRNA mimic or inhibitor caused reciprocal modification of COX2 and CDX2 protein expression, whereas they did not affect COX2 and CDX2 mRNA levels. These data suggested that miR-212-3p and miR-361-3p downregulated COX2 and CDX2 through translation inhibition rather than mRNA degradation.
To clarify the effect of miRNAs on COX2 and CDX2 expression during H. pylori infection, we transfected esophageal epithelial cells with mimic or inhibitor, followed by H. pylori infection. Ectopic miR-212-3p and miR-361-3p dramatically reversed H. pylori induction of COX2 and CDX2, respectively. Thus, H. pylori exerted its effects on esophageal epithelial cells, at least in part, by modulating miRNAs and their downstream target genes. It was notable that COX2 and CDX2 mRNA levels were increased in the prolonged H. pylori exposure study, but not in the miRNA mimic and inhibitor experiments.
Clearly, the effect of H. pylori is not entirely miRNA-dependent.
Moreover, there are potential differences in the mechanism of acute and chronic H. pylori infection, particularly if epigenetic changes that involve DNA replication are involved. Furthermore, as miRNAs have multiple targets, we cannot assume an effect on a single target F I G U R E 5 Helicobacter pylori upregulated COX2 and caudal-type homeobox protein 2 (CDX2) expression by aberrant silencing of microRNAs (miRNAs). A, HET-1A cells were transfected with mimic, inhibitor, or negative control (NC) of miR-212-3p, followed by H. pylori (100 MOI) infection for 48 h. Expression of COX2 was determined by Western blot analysis. B, OE33 cells were transfected with mimic or NC of miR-361-3p followed by H. pylori infection, then the expression of CDX2 was detected. All Western blot bands were quantified and normalized to b-actin, and illustrated by quantitative analysis of COX2 (A) and CDX2 (B) expression. Data are expressed as mean AE SD.*P < .05. All results shown are representative of three independent experiments (ie, COX2 or CDX2) to be the only consequence. Thus, further studies are needed to validate the effects of altering expression of these miRNAs by both H. pylori and genetic manipulation. Wang. Y. Dai was supported by NSFC #81472267.
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